TCBIOvs its industry peers
A metric-by-metric comparison of TCBIO against SIC 6022 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TCBIOThis | — | — | — | — | -37.4%#2 | 326.1%#1 | 770812.1%#1 | 9.5%#4 | — | — | — | — |
| PFBX | — | — | — | — | — | -82.0%#6 | — | 3.8%#6 | 9.3%#3 | — | — | — |
| PTBS | — | — | — | — | — | -156.3%#7 | — | -3.9%#7 | — | — | — | — |
| RBCAA | — | — | — | — | 8.5%#1 | 29.5%#4 | 55.8%#2 | 11.3%#3 | — | — | — | — |
| RVRF | — | — | — | — | — | 34.4%#3 | — | 13.6%#2 | 25.0%#2 | — | — | — |
| SFDL | — | — | — | — | — | 39.4%#2 | — | 6.8%#5 | — | — | — | — |
| UWHR | — | — | — | — | — | 14.6%#5 | — | 16.1%#1 | 104.8%#1 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 6022). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-06.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice